Generate Biomedicines | News

Blog Posts 12.07.2022
Protein re-surfacing of E. coli L‑Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responses
Press Releases 12.07.2022
Generate Biomedicines Expands Board of Directors with Jane Mendillo, Former CEO of The Harvard Management Company
Press Releases 12.06.2022
Generate Biomedicines Expands Leadership Team with Chief Digital Officer
Blog Posts 12.01.2022
Illuminating Protein Space With a Programmable Generative Model
Press Releases 12.01.2022
Generate Biomedicines Uses AI to Create Proteins That Have Never Existed
Press Releases 11.22.2022
Generate Biomedicines Grows Leadership Team with Head of Vaccines and Infectious Disease Research and Senior Vice President of Technical Operations